Edition:
United Kingdom

People: Cerus Corp (CERS.OQ)

CERS.OQ on NASDAQ Stock Exchange Global Market

5.52USD
19 Jul 2019
Change (% chg)

$-0.09 (-1.60%)
Prev Close
$5.61
Open
$5.58
Day's High
$5.60
Day's Low
$5.50
Volume
277,498
Avg. Vol
266,262
52-wk High
$8.05
52-wk Low
$4.49

Witney, Frank 

Dr. Frank Witney is an Independent Director of Cerus Corporation. Dr. Witney’s has served as a member of the Board since March 2014. Dr. Witney has served as President, Chief Executive Officer and a director of Affymetrix, Inc., a provider of life science products and molecular diagnostic products, from July 2011 through March 31, 2016, the date it was acquired by Thermo Fisher Scientific, Inc. Dr. Witney served as President and Chief Executive Officer of Dionex Corporation, a provider of analytical instrumentation and related accessories and chemicals, from April 2009 until its acquisition by Thermo Fisher Scientific, Inc. in May 2011. Between December 2008 and April 2009, Dr. Witney served as Affymetrix’s Executive Vice President and Chief Commercial Officer. Prior to that, Dr. Witney served as President and Chief Executive Officer of Panomics, Inc. from July 2002 to December 2008. Dr. Witney was a post-doctoral fellow at the National Institutes of Health and holds a Ph.D. in Molecular and Cellular Biology and an M.S. in Microbiology from Indiana University, and B.S. in Microbiology from the University of Illinois.

Basic Compensation

Total Annual Compensation, USD 74,000
Restricted Stock Award, USD 69,210
Long-Term Incentive Plans, USD --
All Other, USD 69,210
Fiscal Year Total, USD 212,420

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Daniel Swisher

252,996

William Greenman

2,983,440

Kevin Green

1,022,270

Carol Moore

981,744

William Moore

--

Laurence Corash

1,040,260
As Of  31 Dec 2018